Palatin Technologies (PTN) Other Working Capital Changes (2010 - 2026)
Palatin Technologies' (PTN) quarterly Other Working Capital Changes came in at -$1.1 million in Q1 2026, down 1049.68% on a YoY basis from $115641.1 in Q1 2025, and down 194.31% quarter-over-quarter from $1.2 million in Q4 2025.
Analysis
Palatin Technologies (PTN) Other Working Capital Changes (2010 - 2026) Analysis & Trends
Palatin Technologies (PTN) has reported Other Working Capital Changes for 17 consecutive years, with -$1.1 million the latest figure, recorded in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes fell 1049.68% year-over-year to -$1.1 million; the trailing twelve-month figure through Mar 2026 stood at -$224276.0 (up 23.82% YoY), and the FY2025 full-year result was -$380543.0, up 68.78% from the prior year.
- Other Working Capital Changes retreated to -$1.1 million in Q1 2026 per PTN's latest filing, from $1.2 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $1.5 million in Q2 2022 and bottomed at -$1.6 million in Q4 2023.
- Historically, Other Working Capital Changes has averaged -$17008.1 across 5 years, with a median of -$94223.0 in 2024.
- The sharpest annual moves came in 2023 and 2025: Other Working Capital Changes slumped 7098.71% in 2023, then surged 1335.92% in 2025.
- Over 5 years, Other Working Capital Changes stood at -$22375.0 in 2022, then plunged by 7098.71% to -$1.6 million in 2023, then surged by 94.15% to -$94223.0 in 2024, then soared by 1335.92% to $1.2 million in 2025, then sank by 194.31% to -$1.1 million in 2026.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$1.1 million, $1.2 million, and -$192143.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Palatin Technologies | 46.98 Mn | 46.98 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -1.10 Mn |
| Mar 31, 2026 | -1.10 Mn |
| Dec 31, 2025 | 1.16 Mn |
| Dec 31, 2025 | 1.16 Mn |
| Sep 30, 2025 | -192,143.00 |
| Sep 30, 2025 | -192,143.00 |
| Jun 30, 2025 | -98,439.00 |
| Jun 30, 2025 | -98,439.00 |
| Mar 31, 2025 | -95,524.00 |
| Mar 31, 2025 | -95,524.00 |
| Dec 31, 2024 | -94,223.00 |
| Dec 31, 2024 | -94,223.00 |
| Sep 30, 2024 | -92,357.00 |
| Sep 30, 2024 | -92,357.00 |
| Jun 30, 2024 | -12,282.00 |
| Jun 30, 2024 | -12,282.00 |
| Mar 31, 2024 | -159,400.00 |
| Mar 31, 2024 | -159,400.00 |
| Dec 31, 2023 | -1.61 Mn |
| Dec 31, 2023 | -1.61 Mn |